Scientific & Medical Advisory Council

The Scientific and Medical Advisory Council (SMAC) provides the collective voice and leadership for the Crohn’s and Colitis Canada IBD Research Institute (IBDRI). 

Crohn’s and Colitis Canada relies on guidance from this group of experts as it strives to deliver on its mission to find the cures for Crohn's disease and ulcerative coitis and improve the lives of children and adults affected by these diseases.

The 2017/2018 SMAC includes:

Members Institution
Dr. Mark Silverberg, Chair  University of Toronto, Mount Sinai Hospital
Dr. John Rioux, Vice-Chair  Université de Montréal & Montreal Heart Institute
Dr. Laura Sly University of British Columbia, BC Children's Hospital
Dr. Tony Otley Dalhousie University
Dr. John Marshall McMaster University Medical Centre
Dr. Gil Kaplan Insitute of Public Health, University of Calgary
Dr. Nicola Jones University of Toronto, The Hospital for Sick Children
Dr. Eric Benchimol University of Ottawa, Children's Hospital of Eastern Ontario
Dr. Brian Bressler University of British Columbia, St. Paul's Hospital 

  • Les taux de ces maladies au Canada figurent parmi les plus élevés du monde.
  • 1 CANADIEN SUR 150 VIT AVEC LA MALADIE DE CROHN OU LA COLITE
  • Pour la première fois, les familles nouvellement arrivées au Canada contractent la maladie de Crohn et la colite
  • Depuis 1995, l’incidence de la maladie de Crohn chez les enfants canadiens de 10 ans et moins a presque doublé
  • Les gens sont le plus souvent diagnostiqué avant 30 ans.